143 related articles for article (PubMed ID: 37597677)
1. Effects of schisandra lignans on the absorption of protopanaxadiol-type ginsenosides mediated by P-glycoprotein and protopanaxatriol-type ginsenosides mediated by CYP3A4.
Li Y; Yang K; Zhao L; Xu C; Zhou W; Wang Z; Hu H; You Y
J Ethnopharmacol; 2024 Jan; 318(Pt B):117057. PubMed ID: 37597677
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetic compatibility of ginsenosides and Schisandra Lignans in Shengmai-san: from the perspective of p-glycoprotein.
Liang Y; Zhou Y; Zhang J; Rao T; Zhou L; Xing R; Wang Q; Fu H; Hao K; Xie L; Wang G
PLoS One; 2014; 9(6):e98717. PubMed ID: 24922060
[TBL] [Abstract][Full Text] [Related]
3. A versatile economic strategy by HPLC-CAD for quantification of structurally diverse markers in quality control of Shengmai Formula from raw materials to preparations.
Liu L; Fan W; Zhang H; Fan L; Mei Y; Wang Z; Li L; Yang L; Wang Z
Phytomedicine; 2024 Jul; 129():155625. PubMed ID: 38692077
[TBL] [Abstract][Full Text] [Related]
4. Detection of 13 Ginsenosides (Rb1, Rb2, Rc, Rd, Re, Rf, Rg1, Rg3, Rh2, F1, Compound K, 20(
Jin S; Jeon JH; Lee S; Kang WY; Seong SJ; Yoon YR; Choi MK; Song IS
Molecules; 2019 Jul; 24(14):. PubMed ID: 31323835
[TBL] [Abstract][Full Text] [Related]
5. Interactions of the major effective components in Shengmai formula with breast cancer resistance protein at the cellular and vesicular levels.
Wu L; Liu J; Hou J; Zhan T; Yuan L; Liu F; Xiong Y; Hu J; Xia C
Biomed Pharmacother; 2021 Jan; 133():110939. PubMed ID: 33232930
[TBL] [Abstract][Full Text] [Related]
6. Herb-Drug Interaction of Red Ginseng Extract and Ginsenoside Rc with Valsartan in Rats.
Jeon JH; Lee S; Lee W; Jin S; Kwon M; Shin CH; Choi MK; Song IS
Molecules; 2020 Jan; 25(3):. PubMed ID: 32023909
[TBL] [Abstract][Full Text] [Related]
7. Molecular mechanisms governing different pharmacokinetics of ginsenosides and potential for ginsenoside-perpetrated herb-drug interactions on OATP1B3.
Jiang R; Dong J; Li X; Du F; Jia W; Xu F; Wang F; Yang J; Niu W; Li C
Br J Pharmacol; 2015 Feb; 172(4):1059-73. PubMed ID: 25297453
[TBL] [Abstract][Full Text] [Related]
8. BACE1 molecular docking and anti-Alzheimer's disease activities of ginsenosides.
Choi RJ; Roy A; Jung HJ; Ali MY; Min BS; Park CH; Yokozawa T; Fan TP; Choi JS; Jung HA
J Ethnopharmacol; 2016 Aug; 190():219-30. PubMed ID: 27275774
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics of ginsenosides following repeated oral administration of red ginseng extract significantly differ between species of experimental animals.
Jeon JH; Lee J; Choi MK; Song IS
Arch Pharm Res; 2020 Dec; 43(12):1335-1346. PubMed ID: 33225388
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of cytochrome P450 3A4 activity by schisandrol A and gomisin A isolated from Fructus Schisandrae chinensis.
Wan CK; Tse AK; Yu ZL; Zhu GY; Wang H; Fong DW
Phytomedicine; 2010 Jul; 17(8-9):702-5. PubMed ID: 20089387
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of human CYP3A4 and CYP3A5 enzymes by gomisin C and gomisin G, two lignan analogs derived from Schisandra chinensis.
Zhao J; Sun T; Wu JJ; Cao YF; Fang ZZ; Sun HZ; Zhu ZT; Yang K; Liu YZ; Gonzalez FJ; Yin J
Fitoterapia; 2017 Jun; 119():26-31. PubMed ID: 28344076
[TBL] [Abstract][Full Text] [Related]
12. Multifaceted interaction of the traditional Chinese medicinal herb Schisandra chinensis with cytochrome P450-mediated drug metabolism in rats.
Wang B; Yang S; Hu J; Li Y
J Ethnopharmacol; 2014 Sep; 155(3):1473-82. PubMed ID: 25091466
[TBL] [Abstract][Full Text] [Related]
13. Complex components of Shengmai formula interact with organic cation transporter 2 (OCT2) in MDCK cells.
Meng C; Zhong L; Lu T; Gu Q; Du X; Liu F; Xia C
J Ethnopharmacol; 2023 May; 308():116278. PubMed ID: 36813246
[TBL] [Abstract][Full Text] [Related]
14. Tissue distribution and excretion of herbal components after intravenous administration of a Chinese medicine (Shengmai injection) in rat.
Zhan SY; Shao Q; Fan XH; Li Z; Cheng YY
Arch Pharm Res; 2014 Apr; ():. PubMed ID: 24748511
[TBL] [Abstract][Full Text] [Related]
15. In silico modeling for the nonlinear absorption kinetics of UK-343,664: a P-gp and CYP3A4 substrate.
Abuasal BS; Bolger MB; Walker DK; Kaddoumi A
Mol Pharm; 2012 Mar; 9(3):492-504. PubMed ID: 22264132
[TBL] [Abstract][Full Text] [Related]
16. [Traditional Chinese medicine pairs (III)--effect of extract of Ginseng Radix et Rhizoma and Puerariae Lobatae Radix on intestinal absorption in rats].
Chen YH; Li MX; Meng ZQ; Yang JJ; Huang WZ; Wang ZZ; Wang YS; Xiao W
Zhongguo Zhong Yao Za Zhi; 2015 Aug; 40(15):3094-9. PubMed ID: 26677717
[TBL] [Abstract][Full Text] [Related]
17. Effects of ginseng components on c-DNA-expressed cytochrome P450 enzyme catalytic activity.
Henderson GL; Harkey MR; Gershwin ME; Hackman RM; Stern JS; Stresser DM
Life Sci; 1999; 65(15):PL209-14. PubMed ID: 10574228
[TBL] [Abstract][Full Text] [Related]
18. Schisandra chinensis extract decreases chloroacetaldehyde production in rats and attenuates cyclophosphamide toxicity in liver, kidney and brain.
Zhai J; Zhang F; Gao S; Chen L; Feng G; Yin J; Chen W
J Ethnopharmacol; 2018 Jan; 210():223-231. PubMed ID: 28821392
[TBL] [Abstract][Full Text] [Related]
19. Dextran sulfate sodium-induced colitis and ginseng intervention altered oral pharmacokinetics of cyclosporine A in rats.
Yang Y; Hu N; Gao XJ; Li T; Yan ZX; Wang PP; Wei B; Li S; Zhang ZJ; Li SL; Yan R
J Ethnopharmacol; 2021 Jan; 265():113251. PubMed ID: 32810615
[TBL] [Abstract][Full Text] [Related]
20. In vitro to in vivo evidence of the inhibitor characteristics of Schisandra lignans toward P-glycoprotein.
Liang Y; Zhou Y; Zhang J; Liu Y; Guan T; Wang Y; Xing L; Rao T; Zhou L; Hao K; Xie L; Wang GJ
Phytomedicine; 2013 Aug; 20(11):1030-8. PubMed ID: 23731657
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
